Le Lézard
Classified in: Health
Subjects: PDT, TDS, MAT

Dekang's Innovative Products - DKiss Menthol Flavor Roll-on for Cigarettes & Smokeless Nicotine Inhaler to be Debuted Globally at InterTabac 2023 in Germany


DORTMUND, Germany, Sept. 12, 2023 /PRNewswire/ -- Dekang Biotech Co., Ltd. ("Dekang"), a pioneer in the vaping industry, is gearing up for the InterTabac 2023, a renowned industry fair that runs from September 14-16 in Dortmund, Germany. At booth 2.B18, Dekang will introduce two products that are making their global debut, offering unique solutions to enhance the nicotine experience while prioritizing environmental responsibility.

Dekang's first breakthrough is the DKiss Menthol Flavor Roll-On, set to transform the smoking experience in several ways. It is the easiest way to flavor the cigarettes. The DKiss Menthol Flavor Roll-On is distinguished by its innovative roll-on design, ensuring a clean and convenient application process while allowing users to adjust the intensity based on their preferences.

DKiss Menthol Flavor Roll-On

The DKiss Menthol Flavor Roll-On caters to a diverse audience by offering a wide range of flavor options, including those tailored for individuals sensitive to cigarette odors. This product effectively eradicates cigarette odors and bad breath caused by smoking, serving as a discreet solution for smokers. Mint enthusiasts will appreciate the refreshing mint flavor variant as it cleverly balances the taste of the cigarette and the unpleasant smell it creates, making it an ideal choice for menthol cigarette lovers.

Dekang's second groundbreaking product ? the DKiss Smokeless Nicotine Inhaler ? offers a smoke-free supplement to traditional smoking and vaping. This product serves as a nicotine delivery system (ENDS), providing users with a satisfying nicotine experience without the harmful effects of traditional smoking and vaping.

DKiss Smokeless Nicotine Inhaler

Distinguished by its non-contact heating technology, the DKiss Smokeless Nicotine Inhaler sets itself apart from electronic vapes, ensuring a safer and smoother experience. Designed as a reduced-risk product, it minimizes the health risks, offering a responsible supplement for nicotine users.

The DKiss Smokeless Nicotine Inhaler produces no smoke, making it suitable for use in any setting without impacting the environment or bystanders. Also, users can select from a wide range of flavors, allowing them to customize their nicotine experience.

For more information about Dekang, please visit www.dekangbio.com, or contact us at [email protected] or +86-755-27567890.

Photo - https://mma.prnewswire.com/media/2208037/DKiss_Menthol_Flavor_Roll_On.jpg
Photo - https://mma.prnewswire.com/media/2208038/DKiss_Smokeless_Nicotine_Inhaler.jpg


These press releases may also interest you

at 06:50
Pfizer Inc. highlights its progress in advancing new potential standards of care in Oncology at the 2024 American Society of Clinical Oncology (ASCO®) Annual Meeting, taking place May 31 to June 4 in Chicago. More than 50 abstracts, including 11...

at 06:30
Leica Biosystems is pleased to announce that its flagship digital pathology system, Aperio GT 450 DX, has received 510(k) clearance from the US Food and Drug Administration. Previously sold into the clinical market under an enforcement discretion due...

at 06:17
Local Infusion, a technology-driven provider for patients with chronic autoimmune diseases on specialty infusion therapy, announced the opening of a state-of-the-art infusion center in New Haven, Connecticut. We are excited about our continued...

at 06:05
Revvity, Inc. , today reported financial results for the first quarter ended March 31, 2024. The Company reported GAAP earnings per share of $0.21, as compared to $4.50 in the same period a year ago. GAAP revenue for the quarter was $650 million,...

at 06:00
Theravance Biopharma, Inc. will report its first quarter 2024 financial results and provide a business update after market close on Monday, May 13, 2024. An accompanying conference call and simultaneous webcast will be hosted at 5:00 pm ET (2:00 pm...

at 06:00
Repertoire® Immune...



News published on and distributed by: